A possible role of leptin‐associated increase in soluble interleukin‐2 receptor diminishing a clinical response to infliximab in rheumatoid arthritis: Comment on the article by Klaasen et al
Shin J, Park J, Kim J. A possible role of leptin‐associated increase in soluble interleukin‐2 receptor diminishing a clinical response to infliximab in rheumatoid arthritis: Comment on the article by Klaasen et al. Arthritis & Rheumatism 2011, 63: 2833-2834. PMID: 21618200, DOI: 10.1002/art.30462.Peer-Reviewed Original ResearchConceptsSoluble interleukin-2 receptorClinical response to infliximabResponse to infliximabInterleukin-2 receptorRheumatoid arthritis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply